Search results (196)
« Back to NewsType 1 diabetes research centre at University of Oxford marks its first year
13 Nov, 2026
Scientists and clinicians are making progress towards a better future for people affected by type 1 diabetes, by exploring how to delay the onset of the condition, develop new treatments, and improve everyday care.
Research shows for the first time that standard non-contrast CT scans can be analysed by AI to reveal hidden coronary inflammation
12 Nov, 2026
Researchers from 27 institutions across UK, USA, Europe and Australia, led by a team at the University of Oxford, have demonstrated how an AI technology can measure inflammation in the heart’s arteries using low-radiation CT heart scans typically used to measure calcium score.
£520,000 grant to test treatment for haemophilia-related ankle arthritis
11 Nov, 2026
Dr Nikki Curry from the Radcliffe Department of Medicine, and Steph Taylor from the Oxford Haemophilia & Thrombosis Centre, have been awarded a clinical trial grant from the National Institute of Health and Care Research for Patient Benefit (NIHR RfPB) funding stream to improve treatment for the ankle arthritis caused by haemophilia.
Researchers highlight need for better sleep support for NHS shift workers
6 Nov, 2026
A new study led by researchers at the University of Oxford’s Radcliffe Department of Medicine, has found that many NHS staff working shifts experience sleep difficulties, with researchers calling for more accessible, evidence-based support to help staff manage sleep.
Breakthrough in non-invasive liver testing
2 Nov, 2026
Two major international studies, including an imaging study led by researchers from the Radcliffe Department of Medicine, have provided new evidence on which non-invasive tests can accurately diagnose and measure the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, MASH, potentially reducing reliance on liver biopsy.
Immune sensor can detect viral infection by monitoring cell’s own RNA
13 Oct, 2026
A recent study by the Rehwinkel Group and collaborators reveals a new way the immune sensor MDA5 can recognise viral infection – not only through viral RNA, but by monitoring changes to the cell’s own RNA processing.
Virtual Open Day for Graduate Students 20 October 2026
5 Oct, 2026
Join our online session to learn more about preparing a strong application for an RDM graduate course.
Everyday DNA damage reveals a hidden weakness in some cancers
28 Sep, 2026
Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.
How body fat is stored across organs may reveal hidden health risks, study suggests
7 Sep, 2026
University of Oxford researchers have found that how fat accumulates in the body is just as important for identifying different health risks as a person’s overall weight.
Professor KJ Patel awarded Royal Society Buchanan Medal
27 Aug, 2026
Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.
New RDM Professors of Practice
21 Aug, 2026
The title of Professor of Practice has been conferred upon Meghana Pandit and Sue Pavord, in the recent University Recognition of Distinction exercise.
Professor Leanne Hodson receives Physiological Society Prize Lecture
21 Jul, 2026
The Joan Mott Prize Lecture celebrates women in physiology whose work has demonstrated impact.
New RDM course builds capacity in hyperpolarised MRI
20 Jul, 2026
Researchers, students and imaging specialists from across the UK and Europe recently completed a new training programme in hyperpolarised MRI at Oxford. This course builds expertise in a rapidly developing imaging technology with applications across healthcare and biomedical research.
New personalised therapy targets chronic blood cancer
2 Jul, 2026
A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to a new study led by UCL and University of Oxford researchers.
Professor Jan Rehwinkel receives funding to tackle viral threats
25 Jun, 2026
A research project led by Professor Jan Rehwinkel is one of three innovative Oxford-led projects aimed at transforming how we protect against respiratory viruses, which have secured funding through the UK’s Advanced Research and Invention Agency (ARIA).
Professor KJ Patel awarded major European Research Council Advanced Grant
23 Jun, 2026
Professor Patel is one of fourteen researchers at the University of Oxford awarded Advanced Grants from the European Research Council (ERC), each worth up to €2.5 million over a period of five years.
New studies shed light on how best to guide heart artery procedures
19 Jun, 2026
Three clinical trials have shed new light on which approaches are most useful when treating narrowed heart arteries. They challenge the current guidance on how to insert stents.
Reversing T cell exhaustion improves effectiveness of myeloma immunotherapies
19 May, 2026
Researchers at the Icahn School of Medicine at Mount Sinai, Bristol Myers Squibb (BMS), and the University of Oxford have discovered a way to give worn-out immune cells a second wind in the fight against multiple myeloma.
New AI model predicts how cells choose their fate
12 May, 2026
Researchers from the University of Oxford, the Stowers Institute for Medical Research, Helmholtz Munich, and the Technical University of Munich have developed a new artificial intelligence framework that helps uncover how cells make developmental decisions.